Latest Industry Insights

Technology Networks spoke to Jason Barker, ND, clinical lab educator at Vibrant Wellness, to explore why co-infections from tick bites are frequently underdiagnosed and to examine current and future testing protocols of tick-borne diseases.

In this interview, Technology Networks spoke with Dr. Francesco Dell’Accio and Dr. Suzanne Eldridge to explore the impact of osteoarthritis on patients, the goals of ReFleks and a novel approach to repairing osteochondral defects.

A new pan-European network will integrate long-read sequencing into clinical practice, improving diagnosis of rare diseases and cancers.

In this opinion piece, Philipp Koellinger explores the changes required to level the playing field and accelerate both scientific and technological progress.

Dr. Aaron Wenger tells us about SPRQ chemistry, highlighting its unique benefits and role in expanding our understanding of rare diseases.

Clinical uses of mass spectrometry have historically been limited to specialist facilities. A new solution from Roche automates the entire workflow enabling routine testing laboratories to capitalize on the high sensitivity of mass spectrometry.

Technology Networks had the pleasure of speaking with Dr. Bipin Patel, CEO and founder at electronRx, to learn more about how digital biomarkers could help patients suffering from chronic respiratory disorders.

We interviewed Agilent Technologies at HUPO 2024 to learn about its latest product launch, the Agilent Infinity III LC Series.

Technology Networks spoke with Dr. Mohamed Alameri to explore how population-wide genome initiatives are addressing gaps in genomic data representation and advancing precision medicine in areas such as rare diseases and cancer.

In this article, explore how next-generation protein sequencing is helping to unlock the proteome.